Fig. 1 · Structure
Documents & Downloads
Myristicin
Monamine Oxidase Inhibitor
Myristicin is a weak monoamine oxidase (MAO) inhibitor with notable serotonin receptor antagonist properties. It demonstrates significant biological activities, including anti-cancer effects against gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. Additionally, myristicin exhibits antibacterial, anti-inflammatory, and apoptosis-inducing effects, making it valuable for research in cancer therapeutics and neuropharmacology. Care should be taken regarding its potential psychoactive effects and associated risks when misused.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 607-91-0 |
| Applications | Monamine Oxidase Inhibitor |
| Formula | C11H12O3 |
| Molecular Weight | 192.21 |
| Synonyms | Myristicine |
| SMILES | C=CCC1=CC(OC)=C2OCOC2=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.